https://news1global.com/health/article/443226/News1en2026-10-12T13:03:32+09:00HK inno.N to Present Phase 3 Results for K-CAB in U.S. Patients With Non-Erosive GERD https://news1global.com/uncategorized/article/443225/News1en2026-10-12T13:03:23+09:00HLB Resubmits Liver Cancer Drug Application Three Months After FDA Rejection https://news1global.com/health/article/443223/News1en2026-10-12T13:03:13+09:00‘FDA Is Just the First Step’: Korean Spine Implant Makers Compete in U.S. Operating Rooms https://news1global.com/health/article/443221/News1en2026-10-12T13:03:00+09:00HLB Wins FDA Approval for Riptivo, but Real Test Is Another Bid for Liver Cancer Drug https://news1global.com/health/article/443219/News1en2026-10-12T13:02:49+09:00Lotte Biologics Targets Japan’s Pharma Market, Eyes More Manufacturing Contracts